SPRY
ARS Pharmaceuticals, Inc
4.10$
-1.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 75.4% | 67.3% | 99.9% | 98.8% | 98.7% | 99.3% | 95.2% | 87.0% | |
| 73.2% | 63.8% | 92.9% | 97.7% | 74.8% | 30.4% | 14.5% | 12.6% | |
| 73.2% | 63.8% | 92.9% | 97.7% | 97.5% | 97.9% | 89.4% | 74.8% | |
| – | – | 1.5% | 0.0% | 0.4% | 0.3% | 2.6% | 8.0% | |
| – | – | -9.9% | -11.0% | -0.4% | 0.0% | 1.5% | 2.6% | |
| – | – | 0.1% | 1.1% | 0.1% | – | – | – | |
| – | – | – | – | – | 0.3% | 2.2% | 4.4% | |
| 33.9% | 135.8% | 153.2% | 150.9% | 3.0% | 1.0% | 26.9% | 65.1% | |
| 18.7% | 114.6% | 31.1% | 13.3% | 1.9% | 1.0% | 6.7% | 11.9% | |
| 12.8% | 78.6% | 9.7% | 5.9% | 0.1% | 0.1% | 0.0% | 0.2% | |
| 2.8% | 22.5% | 4.6% | 2.9% | 0.6% | 0.3% | 2.8% | 1.7% | |
| – | – | 28.3% | 8.0% | – | – | – | 29.4% | |
| 66.1% | -35.8% | -53.2% | -50.9% | 97.0% | 99.0% | 73.1% | 34.9% | |
| -144.6% | -407.7% | -83.4% | -68.8% | -27.3% | -56.3% | -35.1% | -89.9% | |
| 120.0% | 211.3% | 131.4% | 47.0% | 14.2% | 40.8% | 29.2% | 30.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.